期刊文献+

食管鳞癌细胞系核苷酸还原酶亚单位M1的表达水平与细胞对吉西他滨敏感性的关系 被引量:3

Relationship between the level of RRM1 expression and the sensitivity to gemcitabine in the esophageal squamous cell carcinoma cell lines
原文传递
导出
摘要 目的探讨食管鳞癌细胞系核苷酸还原酶亚单位M1(RRM1)表达水平与细胞对吉西他滨(GEM)敏感性的关系。方法选用4个人食管鳞癌细胞系Eca-109、Kyse-150、Kyse-450和9706,采用Western blot和逆转录聚合酶链反应(RT—PCR)检测各细胞系的RRM1表达水平,采用细胞毒性试验检测各细胞系对GEM的敏感性。以50nmoL/L GEM持续培养Kyse-450细胞,检测不同时点存活细胞RRM1表达水平的变化。应用RNA干扰技术下调RRMl表达水平后,检测细胞对GEM敏感性的变化。结果GEM作用48h,Eca-109、Kyse-150、Kyse-450和9706细胞的IC50分别为(0.92±0.17)、(0.48±0.11)、(0.29±0.06)和(0.02±0.01)mmol/L。RT—PCR和Western blot结果均显示,Eca-109细胞系的RRM1表达水平最高,其次是Kyse-150和Kyse-450,9706细胞系的RRM1表达水平最低。50nmol/L GEM持续培养Kyse-450细胞后,存活细胞的RRM1水平随着培养时间的延长而逐渐增高。转染RRM1 siRNA的Kyse-450细胞RRM1蛋白的表达水平显著降低,而对GEM的敏感性提高了4.26倍。结论食管鳞癌细胞系RRM1的表达水平与细胞对GEM的敏感性相关,RRM1表达水平低的细胞对GEM相对敏感。 Objective Ribonucleotide reductase subunit M1 (RRM1) is the intracellular target of gemcitabine (GEM). The aim of this study is to explore the relationship between the level of RRM1 expression and the sensitivity to GEM in the esophageal squamous cell carcinoma cell lines. Methods Four esophageal squamous cell carcinoma cell lines (Kyse-150, Kyse-450,9706 and Eca-109) were cultured in vitro. In the same period, RRM1 expression level was measured by RT-PCR and Western blot, and cell sensitivity to GEM was determined by CCK-8 assay. The relation between cell sensitivity and RRM1 expression was further analyzed. Kyse-450 ceils were continuously cultured in the medium containing 50 nM GEM. RRM1 expression was measured at different time points to monitor the dynamic changes in the surviving cells. Inhibition of RRM1 expression by RNAi method was applied and the effect on GEM- sensitivity was further examined. Results The IC50 of Eca-109, Kyse-150, Kyse-450 and 9706 cells were (0.92 ±0. 17), (0.48 ±0. 11), (0.29±0.06) and (0.02±0.01) mmol/L, respectively. The expressions of RRM1 protein and mRNA of Eca-109 cell line were the highest detected by Western blot and RT-PCR, followed by Kyse-150 and Kyse-450, and the lowest one was 9706 cell line. When Kyse-450 cells were continuously treated with 50 nmol/L GEM, the level of RRM1 protein was increasing in the surviving cells. RRM1 siRNA could effectively knock down the expression of RRM1 and significantly increase the cell sensitivity to GEM (P = 0. 035 ). Conclusion The level of RRM1 expression corelates with the cell sensitivity to gemcitabine. The cells with a lower level of RRM1 expression are more sensitive to gemcitabine.
出处 《中华肿瘤杂志》 CAS CSCD 北大核心 2009年第9期660-663,共4页 Chinese Journal of Oncology
关键词 食管肿瘤 鳞状细胞 吉西他滨 核苷酸还原酶亚单位M1 Esophageal neoplasms Carcinoma, squamous cell Gemcitabine RRM1
  • 相关文献

参考文献13

  • 1Millar J, Scullin P, Morrison A, et al. Phase Ⅱ study of gemcitabine and cisplatin in locally advanced/metastatic oesophageal cancer. Br J Cancer, 2005, 93:1112-1116.
  • 2Kroep JR, Pinedo HM, Giaccone G, et al. Phase Ⅱ study of cisplatin preceding gemcitabine in patients with advanced oesophageal cancer. Ann Oncol, 2004, 15:230-235.
  • 3Lorenzen S, Duyster J, Lersch C, et al. Capecitabine plus docetaxel every 3 weeks in first- and second-line metastatic oesophageal cancer : final results of a phase Ⅱ trial. Br J Cancer, 2005, 92 : 2129-2133.
  • 4Assersohn L, Brown G, Cunningham D, et al. Phase Ⅱ study of irinotecan and 5-fluorouracil/leucovorin in patients with primary refractory or relapsed advanced oesophageal and gastric carcinoma. Ann Oncol, 2004, 15:64-69.
  • 5Bepler G, Kusmartseva I, Sharma S, et al. RRM1 modulated in vitro and in vivo efficacy of gemcitabine and platinum in non-small- cell lung cancer. J C lin Oucol, 2006, 24:4731-4737.
  • 6徐兵河.耐药问题和对策//孙燕,石远凯.临床肿瘤内科手册.第5版.北京:人民卫生出版社,2007:194-195.
  • 7Evans WE, Relling MV. Pharmacogenomics: translating functional genomics into rational therapeutics. Science, 1999, 286: 487- 491.
  • 8Evans WE, McLeod HL. Pharmacogenomics -- drug disposition, drug targets, and side effects. N Engl J Med, 2003, 348:538- 549.
  • 9Davidson JD, Ma L, Flagella M, et al. An increase in the expression of ribonucleotide reductase large subunit 1 is associated with gemcitabine resistance in non-small cell lung cancer cell lines. Cancer Res, 2004, 64:3761-3766.
  • 10Rosen R, Danenberg KD, Albemla V, et al. Ribonucleotide reductase messenger RNA expression and survival in gemcitabine/cisplatintreated advanced non-small cell lung cancer patients. Clin Cancer Res, 2004, 10 : 1318-1325.

同被引文献23

  • 1廖日强,林嘉颖,乔贵宾,骆新兰,杨衿记,黄玉娟,吴一龙.非小细胞肺癌组织芯片中RRM1表达和预后因子分析[J].中国肺癌杂志,2006,9(5):423-427. 被引量:20
  • 2韩宝惠.药物基因组学研究与肺癌个体化治疗[J].中华肿瘤防治杂志,2007,14(11):801-804. 被引量:6
  • 3Wachters FM, Wong LS, Timens W, et al. ERCC1, hRad51, and BRCA1 protein expression in relation to tumour re-spottse and suIvival of stage III/IV NSCLC patients treated with chemotherapy[J]. Lung Cancer, 2005, 50(2):211-219.
  • 4Demeure M J, Stephan E, Sinari S, et al. Preclinical investigation of nanoparticle albumin-bound paclitaxel as a po- tential treatment for adrenocortical cancer[J]. Ann Surg, 2012, 255(1):140-146.
  • 5Radosa MP, Hafner N, Camara O, et al. Loss of BRCA1 protein expression as indicator of the BRCAness phenotype is associated with favorable overall survival after complete resection of sporadic ovarian cancer[J]. Int J Gynecol Cancer, 2011, 21(8):1399-1406.
  • 6Renemans P, Vcrstraeten RA, Vcrheijen RH. Oncogenic pathways in hereditary and sporadic breast cancer[J]. Ma- turitas, 2004, 49(1):34-43.
  • 7Wei SZ, Zhan P, Shi MQ, et al. Predictive value of ERCC1 and XPD polymorphism in patients with advanced non- small cell lung cancer receiving platinum-based chemo- therapy: a systematic review and meta-analysis[J]. Med On- col, 2011, 28(1):315-321.
  • 8Ueda S, Shirabe K, Morita K, et al. Evaluation of ERCC 1 expression for cisplatin sensitivity in human hepatocellular carcinoma[J]. Ann Surg Oncol, 2011, 18(4): 1204-1211.
  • 9Wong A, Soo RA, Yong WP, et al. Clinical pharmacology and pharmacogenetics of gemcitabine[J]. Drug Metab Rev, 2009, 41(2):77-88.
  • 10SIEGEL R,NAISHADHAM D,JEMAL A. Cancer statistics,2012[J].CA:A Cancer Journal for Clinicians,2012,(01):10-29.

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部